These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 9808561

  • 1. Association between ligand-induced conformational changes of integrin IIbbeta3 and IIbbeta3-mediated intracellular Ca2+ signaling.
    Honda S, Tomiyama Y, Aoki T, Shiraga M, Kurata Y, Seki J, Matsuzawa Y.
    Blood; 1998 Nov 15; 92(10):3675-83. PubMed ID: 9808561
    [Abstract] [Full Text] [Related]

  • 2. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
    Aoki T, Tomiyama Y, Honda S, Senzaki K, Tanaka A, Okubo M, Takahashi F, Takasugi H, Seki J.
    Thromb Haemost; 1998 Jun 15; 79(6):1184-90. PubMed ID: 9657446
    [Abstract] [Full Text] [Related]

  • 3. RGD-ligand mimetic antagonists of integrin alphaIIbbeta3 paradoxically enhance GPVI-induced human platelet activation.
    Jones ML, Harper MT, Aitken EW, Williams CM, Poole AW.
    J Thromb Haemost; 2010 Mar 15; 8(3):567-76. PubMed ID: 20002543
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets.
    Schwarz M, Meade G, Stoll P, Ylanne J, Bassler N, Chen YC, Hagemeyer CE, Ahrens I, Moran N, Kenny D, Fitzgerald D, Bode C, Peter K.
    Circ Res; 2006 Jul 07; 99(1):25-33. PubMed ID: 16778135
    [Abstract] [Full Text] [Related]

  • 6. Von Willebrand factor can support platelet aggregation via interaction with activated GPIIb-IIIa and GPIb.
    Naimushin YA, Mazurov AV.
    Platelets; 2004 Nov 07; 15(7):419-25. PubMed ID: 15745313
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synergistic outside-in regulation of platelet activation by GPIIb/IIIa ligand-induced conformation and oligomerization.
    Wang XF, Liu F, Morris SA, Carroll RC.
    Thromb Res; 2001 Nov 15; 104(4):239-47. PubMed ID: 11728525
    [Abstract] [Full Text] [Related]

  • 9. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
    Khaspekova SG, Vyzova TV, Lukin VV, Tikhomirov OIu, Berndt M, Kouns W, Mazurov AV.
    Biokhimiia; 1996 Mar 15; 61(3):412-28. PubMed ID: 8724599
    [Abstract] [Full Text] [Related]

  • 10. Differential expression of a ligand induced binding site (LIBS) by GPIIb-IIIa ligand recognition peptides and parenteral antagonists.
    Jennings LK, Haga JH, Slack SM.
    Thromb Haemost; 2000 Dec 15; 84(6):1095-102. PubMed ID: 11154119
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Human platelet activation is inhibited by the occupancy of glycoprotein IIb/IIIa receptor.
    Padoin E, Alexandre A, Cavallini L, Polverino de Laureto P, Rao GH, Doni MG.
    Arch Biochem Biophys; 1996 Sep 15; 333(2):407-13. PubMed ID: 8809080
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A sequence within the cytoplasmic tail of GpIIb independently activates platelet aggregation and thromboxane synthesis.
    Stephens G, O'Luanaigh N, Reilly D, Harriott P, Walker B, Fitzgerald D, Moran N.
    J Biol Chem; 1998 Aug 07; 273(32):20317-22. PubMed ID: 9685382
    [Abstract] [Full Text] [Related]

  • 17. Antibodies causing thrombocytopenia in patients treated with RGD-mimetic platelet inhibitors recognize ligand-specific conformers of αIIb/β3 integrin.
    Bougie DW, Rasmussen M, Zhu J, Aster RH.
    Blood; 2012 Jun 28; 119(26):6317-25. PubMed ID: 22490676
    [Abstract] [Full Text] [Related]

  • 18. Selective induction of a glycoprotein IIIa ligand-induced binding site by fibrinogen and von Willebrand factor.
    Mondoro TH, Wall CD, White MM, Jennings LK.
    Blood; 1996 Nov 15; 88(10):3824-30. PubMed ID: 8916946
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Platelet glycoprotein IIb/IIIa antagonists: lessons learned from clinical trials and future directions.
    Leclerc JR.
    Crit Care Med; 2002 May 15; 30(5 Suppl):S332-40. PubMed ID: 12004256
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.